589051210	589051210	CD	B-NP	O
|	|	NN	I-NP	O
BH	BH	NN	I-NP	O
|	|	NN	I-NP	O
19459871	19459871	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
210138	210138	CD	B-NP	O
|	|	CC	I-NP	O
8/18/2001	8/18/2001	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
RULE	RULE	NNP	I-NP	I-protein
OUT	OUT	NNP	I-NP	I-protein
MYOCARDIAL	MYOCARDIAL	NNP	I-NP	I-protein
INFARCTION	INFARCTION	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/19/2001	4/19/2001	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/17/2001	10/17/2001	CD	B-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
UNSTABLE	UNSTABLE	NN	B-NP	O
ANGINA	ANGINA	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CORONARY	CORONARY	NN	B-NP	O
ARTERY	ARTERY	NN	I-NP	O
DISEASE	DISEASE	NN	I-NP	O
,	,	,	O	O
STATUS	STATUS	NN	B-NP	O
POST	POST	NN	I-NP	O
STENT	STENT	NN	I-NP	O
OF	OF	IN	B-PP	O
THE	THE	DT	B-NP	O
RCA	RCA	NN	I-NP	B-protein
.	.	.	O	O

OTHER	OTHER	NNP	B-NP	O
SIGNIFICANT	SIGNIFICANT	NNP	I-NP	O
PROBLEMS	PROBLEMS	NNP	I-NP	O
:	:	:	O	O
EXTENSIVE	EXTENSIVE	NNP	B-NP	O
CARDIAC	CARDIAC	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
,	,	,	O	O
DVT	DVT	NNP	B-NP	O
WITH	WITH	NNP	I-NP	O
PE	PE	NNP	I-NP	O
X	X	NNP	I-NP	O
TWO	TWO	NNP	I-NP	O
,	,	,	O	O
CHRONIC	CHRONIC	NNP	B-NP	O
RENAL	RENAL	NNP	I-NP	O
INSUFFICIENCY	INSUFFICIENCY	NNP	I-NP	O
,	,	,	O	O
HEPATITIS	HEPATITIS	NN	B-NP	O
B	B	NN	I-NP	O
POSITIVE	POSITIVE	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
63-year-old	63-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
unstable	unstable	JJ	B-NP	O
angina	angina	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
first	first	JJ	I-NP	O
presentation	presentation	NN	I-NP	O
with	with	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
disease	disease	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
1986	1986	CD	B-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
ruled	rule	VBD	B-VP	O
in	in	IN	B-PP	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
cath	cath	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
circumflex	circumflex	NN	I-NP	O
,	,	,	O	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
D1	D1	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
subsequent	subsequent	JJ	I-NP	O
angioplasty	angioplasty	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
circ	circ	NN	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
70	70	CD	I-NP	O
%	%	NN	I-NP	O
residual	residual	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
exercise	exercise	NN	I-NP	O
treadmill	treadmill	NN	I-NP	O
two	two	CD	B-NP	O
months	month	NNS	I-NP	O
later	later	RB	B-ADVP	O
and	and	CC	O	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
cath	cath	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
showed	show	VBD	B-VP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
restenosis	restenosis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
circ	circ	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
60	60	CD	I-NP	O
%	%	NN	I-NP	O
LAD	LAD	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
D1	D1	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
1992	1992	CD	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
again	again	RB	B-ADVP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
exertional	exertional	JJ	B-NP	O
angina	angina	NN	I-NP	O
.	.	.	O	O

Cath	Cath	NNP	B-NP	O
revealed	reveal	VBD	B-VP	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
RCA	RCA	NN	I-NP	B-protein
,	,	,	O	O
70-80	70-80	CD	B-NP	O
%	%	NN	I-NP	O
LAD	LAD	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
diffuse	diffuse	JJ	B-NP	O
disease	disease	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
circumflex	circumflex	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
50	50	CD	I-NP	O
%	%	NN	I-NP	O
mid-circumflex	mid-circumflex	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
diffuse	diffuse	JJ	B-NP	O
global	global	JJ	I-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
40-50	40-50	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
angina	angina	NN	I-NP	O
progressed	progress	VBD	B-VP	O
and	and	CC	O	O
in	in	IN	B-PP	O
1994	1994	CD	B-NP	O
he	he	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
four	four	CD	I-NP	O
vessel	vessel	NN	I-NP	O
CABG	CABG	NN	I-NP	O
,	,	,	O	O
SVG	SVG	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
PDA	PDA	NN	I-NP	O
and	and	CC	I-NP	O
OM-1	OM-1	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
LIMA	LIMA	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
LAD	LAD	NN	I-NP	O
and	and	CC	I-NP	O
D2	D2	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
until	until	IN	B-PP	O
1997	1997	CD	B-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
presyncope	presyncope	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
massive	massive	JJ	I-NP	O
saddle	saddle	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
embolism	embolism	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
hypercoagulative	hypercoagulative	JJ	I-NP	O
workup	workup	NN	I-NP	O
after	after	IN	B-PP	O
this	this	DT	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
recent	recent	JJ	I-NP	O
years	year	NNS	I-NP	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
epigastric	epigastric	JJ	B-NP	B-protein
pain	pain	NN	I-NP	I-protein
with	with	IN	B-PP	O
exertion	exertion	NN	B-NP	O
and	and	CC	O	O
positive	positive	JJ	B-NP	O
stress	stress	NN	I-NP	O
tests	test	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
additional	additional	JJ	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarctions	infarction	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	B-protein
most	most	RBS	I-NP	O
recent	recent	JJ	I-NP	O
cath	cath	NN	I-NP	O
in	in	IN	B-PP	O
July	July	NNP	B-NP	O
of	of	IN	B-PP	O
1997	1997	CD	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
occluded	occluded	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
,	,	,	O	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
LAD	LAD	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
subtotal	subtotal	JJ	B-NP	O
occlusion	occlusion	NN	I-NP	O
distally	distally	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
60	60	CD	I-NP	O
%	%	NN	I-NP	O
mid-RCA	mid-RCA	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
patent	patent	NN	B-NP	O
SVG	SVG	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
PDA	PDA	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
OM	OM	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
LIMA	LIMA	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
LAD	LAD	NN	I-NP	B-protein
.	.	.	O	O

In	In	IN	B-PP	O
recent	recent	JJ	B-NP	O
months	month	NNS	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
describes	describe	VBZ	B-VP	O
increasing	increase	VBG	B-NP	O
frequency	frequency	NN	I-NP	O
of	of	IN	B-PP	O
anginal	anginal	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
provoked	provoke	VBN	B-VP	O
by	by	IN	B-PP	O
walking	walk	VBG	B-VP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
five	five	CD	I-NP	O
minutes	minute	NNS	I-NP	O
or	or	CC	O	O
climbing	climb	VBG	B-VP	O
stairs	stair	NNS	B-NP	O
.	.	.	O	O

Most	Most	RBS	B-ADVP	O
often	often	RB	I-ADVP	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
is	be	VBZ	B-VP	O
epigastric	epigastric	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
occasionally	occasionally	RB	B-ADJP	O
substernal	substernal	JJ	I-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
associated	associated	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
diaphoresis	diaphoresis	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
radiation	radiation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
says	say	VBZ	B-VP	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
hard	hard	JJ	B-ADJP	O
to	to	TO	B-VP	O
catch	catch	VB	I-VP	O
his	his	PRP$	B-NP	O
breath	breath	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denies	deny	VBZ	B-VP	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
PND	PND	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
never	never	RB	I-VP	O
had	have	VBD	I-VP	O
pain	pain	NN	B-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
February	February	NNP	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
an	an	DT	B-NP	O
exercise	exercise	NN	I-NP	O
treadmill	treadmill	NN	I-NP	O
test	test	NN	I-NP	O
walking	walk	VBG	B-VP	O
five	five	CD	B-NP	O
minutes	minute	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
standard	standard	JJ	I-NP	O
Bruce	Bruce	NNP	I-NP	O
protocol	protocol	NN	I-NP	O
,	,	,	O	O
reaching	reach	VBG	B-VP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
96	96	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
130/70	130/70	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
1	1	CD	B-NP	O
mm	mm	NN	I-NP	O
ST	ST	NN	I-NP	O
depressions	depression	NNS	I-NP	O
.	.	.	O	O

Since	Since	IN	B-PP	O
then	then	RB	B-ADVP	O
his	his	PRP$	B-NP	O
angina	angina	NN	I-NP	O
has	have	VBZ	B-VP	O
occurred	occur	VBN	I-VP	O
with	with	IN	B-PP	O
less	less	JJR	B-NP	O
and	and	CC	I-NP	O
less	less	JJR	I-NP	O
exertion	exertion	NN	I-NP	O
until	until	IN	B-SBAR	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
walked	walk	VBD	B-VP	O
outside	outside	JJ	B-NP	O
and	and	CC	I-NP	O
experienced	experienced	JJ	I-NP	O
substernal	substernal	JJ	I-NP	O
chest	chest	NN	I-NP	O
tightness	tightness	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
again	again	RB	B-ADVP	O
denies	deny	VBZ	B-VP	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
diaphoresis	diaphoresis	NN	B-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
radiation	radiation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
some	some	DT	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pain	pain	NN	I-NP	O
lasts	last	VBZ	B-VP	O
approximately	approximately	RB	B-NP	O
10-15	10-15	CD	I-NP	O
minutes	minute	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
advised	advise	VBN	I-VP	O
by	by	IN	B-PP	O
his	his	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Raymond	Raymond	NNP	I-NP	O
Merrihew	Merrihew	NNP	I-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
come	come	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Emergent	Emergent	NNP	I-NP	O
Department	Department	NNP	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
Emergent	Emergent	NNP	I-NP	O
Department	Department	NNP	I-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
pain	pain	NN	B-NP	O
free	free	JJ	I-NP	O
and	and	CC	I-NP	O
received	received	JJ	I-NP	O
aspirin	aspirin	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

CK	CK	NN	B-NP	B-protein
was	be	VBD	B-VP	O
47	47	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
troponin	troponin	NN	I-NP	O
of	of	IN	B-PP	O
0.24	0.24	CD	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Diabetes	Diabete	NNS	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
DVTs	DVT	NNS	I-NP	O
with	with	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
embolism	embolism	NN	I-NP	O
x	x	SYM	O	O
two	two	CD	B-NP	O
,	,	,	O	O
CVA	CVA	NN	B-NP	B-protein
,	,	,	O	O
left	leave	VBD	B-VP	O
temporal	temporal	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
of	of	IN	B-PP	O
4	4	CD	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
residual	residual	JJ	I-NP	O
memory	memory	NN	I-NP	O
and	and	CC	O	O
expressive	expressive	JJ	B-NP	O
deficits	deficit	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
now	now	RB	B-ADVP	O
on	on	IN	B-PP	O
Lovenox	Lovenox	NN	B-NP	O
subcu	subcu	NN	I-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.5	1.5	CD	B-NP	O
,	,	,	O	O
hepatitis	hepatitis	NN	B-NP	O
B	B	NN	I-NP	O
positive	positive	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
recent	recent	JJ	B-NP	O
eye	eye	NN	I-NP	O
surgery	surgery	NN	I-NP	O
in	in	IN	B-PP	O
January	January	NNP	B-NP	O
of	of	IN	B-PP	O
2001	2001	CD	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Benadryl	Benadryl	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
causes	cause	VBZ	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Glucophage	Glucophage	NN	B-NP	O
1000	1000	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
glyburide	glyburide	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Avandia	Avandia	NNP	B-NP	O
4	4	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
gemfibrozil	gemfibrozil	NN	B-NP	O
600	600	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
Lipitor	Lipitor	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

INITIAL	INITIAL	NNP	B-NP	O
PHYSICAL	PHYSICAL	NNP	I-NP	O
EXAM	EXAM	NNP	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	B-protein
98.6	98.6	CD	I-NP	I-protein
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
60	60	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
110/90	110/90	CD	I-NP	O
,	,	,	O	O
upper	upper	JJ	B-NP	O
70	70	CD	I-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
L	L	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
general	general	JJ	B-ADJP	O
,	,	,	O	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
63-year-old	63-year-old	JJ	I-NP	O
Asian	Asian	JJ	I-NP	O
male	male	NN	I-NP	O
,	,	,	O	O
well	well	RB	B-ADJP	O
appearing	appear	VBG	I-ADJP	O
and	and	CC	O	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Pupils	Pupil	NNS	B-NP	O
equal	equal	JJ	B-ADJP	O
,	,	,	O	O
round	round	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
reactive	reactive	JJ	B-ADJP	O
.	.	.	O	O

Extraocular	Extraocular	JJ	B-NP	O
muscles	muscle	NNS	I-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
mucosa	mucosa	NN	I-NP	O
are	be	VBP	B-VP	O
moist	moist	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
jugular	jugular	JJ	I-NP	O
venous	venous	JJ	I-NP	O
distention	distention	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
supple	supple	NN	B-NP	O
.	.	.	O	O

LUNGS	LUNGS	NN	B-NP	O
:	:	:	O	O
Clear	Clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
,	,	,	O	O
without	without	IN	B-PP	O
wheezes	wheeze	NNS	B-NP	O
or	or	CC	I-NP	O
rales	rale	NNS	I-NP	O
.	.	.	O	O

CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
without	without	IN	B-PP	O
murmurs	murmur	NNS	B-NP	O
,	,	,	O	O
rubs	rub	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
gallops	gallop	NNS	B-NP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
,	,	,	I-NP	O
and	and	CC	I-NP	O
mildly	mildly	RB	I-NP	O
tender	tender	NN	I-NP	O
to	to	TO	B-PP	O
palpation	palpation	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
epigastrium	epigastrium	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
rebound	rebound	NN	I-NP	O
or	or	CC	I-NP	O
guarding	guarding	NN	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
are	be	VBP	B-VP	O
warm	warm	JJ	B-ADJP	O
and	and	CC	O	O
well	well	RB	B-ADJP	O
perfused	perfuse	VBN	I-ADJP	O
,	,	,	O	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

INITIAL	INITIAL	JJ	B-NP	O
LABORATORIES	LABORATORIES	NN	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
140	140	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.7	4.7	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
106	106	CD	I-NP	O
,	,	,	O	O
bicarb	bicarb	NN	B-NP	O
24	24	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NNP	B-NP	O
15	15	CD	I-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.5	1.5	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
253	253	CD	I-NP	O
,	,	,	O	O
white	white	JJ	B-NP	O
count	count	NN	I-NP	O
5.3	5.3	NN	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
36.8	36.8	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-protein
144	144	CD	B-NP	I-protein
,	,	,	O	O
calcium	calcium	NN	B-NP	O
9.5	9.5	CD	I-NP	O
,	,	,	O	O
mag	mag	NN	B-NP	O
1.7	1.7	CD	I-NP	O
,	,	,	O	O
CK	CK	NN	B-NP	B-protein
47	47	CD	I-NP	I-protein
,	,	,	O	O
troponin	troponin	NN	B-NP	O
slightly	slightly	RB	B-ADJP	O
elevated	elevated	JJ	I-ADJP	O
at	at	IN	B-PP	O
0.23	0.23	CD	B-NP	O
,	,	,	O	O
INR	INR	NN	B-NP	O
1.1	1.1	CD	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
reveals	reveal	VBZ	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
60	60	CD	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
axis	axis	NN	I-NP	O
and	and	CC	O	O
inferiorly	inferiorly	RB	B-NP	O
flattened	flatten	VBN	I-NP	O
T	T	NN	I-NP	O
waves	wave	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
T	T	NN	B-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
L	L	NN	B-NP	O
in	in	IN	B-PP	O
6	6	CD	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Cardiovascularly	Cardiovascularly	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	O
and	and	CC	O	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
by	by	IN	B-PP	O
CKs	CK	NNS	B-NP	B-protein
.	.	.	O	O

On	On	IN	B-PP	O
10/21	10/21	CD	B-NP	O
he	he	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
80	80	CD	I-NP	O
%	%	NN	I-NP	O
proximal	proximal	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
,	,	,	O	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
proximal	proximal	JJ	I-NP	O
circ	circ	NN	I-NP	O
,	,	,	O	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
proximal	proximal	JJ	I-NP	O
RCA	RCA	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
proximal	proximal	JJ	I-NP	O
right	right	JJ	I-NP	O
PDA	PDA	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
LIMA	LIMA	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
D2	D2	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
LAD	LAD	NN	I-NP	O
were	be	VBD	B-VP	O
patent	patent	NN	B-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
SVG	SVG	NN	I-NP	O
to	to	TO	B-PP	O
OM-1	OM-1	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
SVG	SVG	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
RCA	RCA	NN	I-NP	B-protein
was	be	VBD	B-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
occluded	occlude	VBD	B-VP	O
.	.	.	O	O

A	A	DT	B-NP	O
stent	stent	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
native	native	JJ	I-NP	O
mid-RCA	mid-RCA	NN	I-NP	O
and	and	CC	I-NP	O
angioplasty	angioplasty	NN	I-NP	O
was	be	VBD	B-VP	O
undertaken	undertake	VBN	I-VP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
PDA	PDA	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
heparin	heparin	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
transitioned	transitione	VBN	I-VP	O
to	to	TO	B-PP	O
Lovenox	Lovenox	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
subcu	subcu	NN	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
echo	echo	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
mildly	mildly	RB	B-NP	O
enlarged	enlarge	VBN	I-NP	O
left	left	JJ	I-NP	O
ventricle	ventricle	NN	I-NP	O
with	with	IN	B-PP	O
moderate	moderate	JJ	B-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
function	function	NN	B-NP	O
and	and	CC	I-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
35	35	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
thinning	thin	VBG	I-VP	O
and	and	CC	O	O
hypokinesis	hypokinesis	NN	B-NP	O
to	to	TO	B-PP	O
akinesis	akinesis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
posterior	posterior	JJ	I-NP	O
and	and	CC	I-NP	O
inferior	inferior	JJ	I-NP	O
segments	segment	NNS	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
hypokinesis	hypokinesis	NN	B-NP	O
to	to	TO	B-PP	O
akinesis	akinesis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
distal	distal	JJ	I-NP	O
septum	septum	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
RV	RV	NN	I-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
artery	artery	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
are	be	VBP	B-VP	O
25	25	CD	B-NP	O
+	+	SYM	I-NP	O
right	right	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continues	continue	VBZ	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
epigastric	epigastric	JJ	B-NP	O
discomfort	discomfort	NN	I-NP	O
and	and	CC	I-NP	O
belching	belching	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
revealed	reveal	VBD	B-VP	O
only	only	RB	B-NP	O
nonspecific	nonspecific	JJ	I-NP	O
T	T	NN	I-NP	O
wave	wave	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
scheduled	schedule	VBN	I-VP	O
to	to	TO	I-VP	O
undergo	undergo	VB	I-VP	O
a	a	DT	B-NP	O
submax	submax	NN	I-NP	O
exercise	exercise	NN	I-NP	O
treadmill	treadmill	NN	I-NP	O
test	test	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
troponin	troponin	NN	I-NP	O
initially	initially	RB	B-ADVP	O
from	from	IN	B-PP	O
.23	.23	CD	B-NP	O
to	to	TO	B-PP	O
.73	.73	CD	B-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
having	have	VBG	I-VP	O
some	some	DT	B-NP	O
mild	mild	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
likely	likely	JJ	I-NP	O
culprit	culprit	NN	I-NP	O
being	be	VBG	B-VP	O
the	the	DT	B-NP	O
small	small	JJ	I-NP	O
PDA	PDA	NN	I-NP	O
that	that	WDT	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
angioplastied	angioplastie	VBN	I-VP	O
during	during	IN	B-PP	O
cath	cath	NN	B-NP	O
.	.	.	O	O

Recath	Recath	NN	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
low	low	JJ	B-NP	O
yield	yield	NN	I-NP	O
without	without	IN	B-PP	O
anything	anything	NN	B-NP	O
to	to	TO	B-PP	O
intervene	intervene	NN	B-NP	O
upon	upon	IN	B-PP	O
after	after	IN	B-PP	O
discussion	discussion	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
interventional	interventional	JJ	I-NP	O
Cardiology	Cardiology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
medical	medical	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
was	be	VBD	B-VP	O
maximized	maximize	VBN	I-VP	O
and	and	CC	O	O
included	include	VBD	B-VP	O
a	a	DT	B-NP	O
beta	beta	NN	I-NP	O
blocker	blocker	NN	I-NP	O
,	,	,	O	O
ACE	ACE	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
nitrates	nitrate	NNS	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
trended	trend	VBD	B-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
CK	CK	NN	I-NP	B-protein
of	of	IN	B-PP	O
32	32	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
troponin	troponin	NN	I-NP	O
of	of	IN	B-PP	O
0.33	0.33	CD	B-NP	O
upon	upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
submaximum	submaximum	JJ	B-NP	O
ETT	ETT	NN	I-NP	O
on	on	IN	B-PP	O
3/10	3/10	CD	B-NP	O
and	and	CC	O	O
walked	walk	VBD	B-VP	O
for	for	IN	B-PP	O
nine	nine	CD	B-NP	O
minutes	minute	NNS	I-NP	O
without	without	IN	B-PP	O
EKG	EKG	NN	B-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
did	do	VBD	B-VP	O
experience	experience	NN	B-NP	O
6/10	6/10	CD	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
some	some	DT	B-NP	O
belching	belching	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
test	test	NN	I-NP	O
was	be	VBD	B-VP	O
considered	consider	VBN	I-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
but	but	CC	B-NP	O
not	not	RB	I-NP	O
diagnostic	diagnostic	JJ	I-ADJP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
reached	reach	VBD	B-VP	O
a	a	DT	B-NP	O
max	max	NN	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
68	68	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
142/80	142/80	CD	B-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
submaximum	submaximum	JJ	I-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
close	close	JJ	B-NP	O
follow-up	follow-up	NN	I-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Devin	Devin	NNP	I-NP	O
Peachey	Peachey	NNP	I-NP	O
He	He	NNP	I-NP	O
will	will	MD	B-VP	O
also	also	RB	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
follow-up	follow-up	JJ	I-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
see	see	VB	I-VP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Panciera	Panciera	NNP	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
monitoring	monitoring	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
other	other	JJ	I-NP	O
medical	medical	JJ	I-NP	O
issues	issue	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
his	his	PRP$	B-NP	O
diabetes	diabetes	NN	I-NP	O
.	.	.	O	O

Discharge	Discharge	NN	B-NP	O
condition	condition	NN	I-NP	O
is	be	VBZ	B-VP	O
stable	stable	JJ	B-ADJP	O
,	,	,	O	O
discharge	discharge	NN	B-NP	O
diet	diet	NN	I-NP	O
is	be	VBZ	B-VP	O
low	low	JJ	B-NP	O
fat	fat	JJ	I-NP	O
diabetic	diabetic	JJ	I-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
discharge	discharge	NN	B-NP	O
medications	medication	NNS	I-NP	O
are	be	VBP	B-VP	O
enteric	enteric	JJ	B-NP	O
coated	coat	VBN	I-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
gemfibrozil	gemfibrozil	NN	B-NP	O
600	600	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
glyburide	glyburide	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Isordil	Isordil	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	O
0.4	0.4	CD	I-NP	O
mg	mg	NN	I-NP	O
one	one	CD	B-NP	O
tab	tab	NN	I-NP	O
sublingual	sublingual	JJ	I-NP	O
a.q.	a.q.	NN	I-NP	O
5	5	CD	B-NP	O
minutes	minute	NNS	I-NP	O
x	x	SYM	B-NP	O
three	three	CD	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
ramipril	ramipril	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Lovenox	Lovenox	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
subcu	subcu	NN	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
x	x	SYM	O	O
70	70	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
x	x	SYM	O	O
25	25	CD	B-NP	O
days	day	NNS	I-NP	O
-LRB-	-LRB-	IN	B-PP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
30	30	CD	B-NP	O
days	day	NNS	I-NP	O
since	since	IN	B-PP	O
the	the	DT	B-NP	O
stent	stent	JJ	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
Lipitor	Lipitor	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Avandia	Avandia	NNP	B-NP	O
4	4	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
TORY	TORY	NNP	B-NP	O
GETACHEW	GETACHEW	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
BH71	BH71	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
DANTE	DANTE	NNP	B-NP	O
H.	H.	NNP	I-NP	O
DENEGRE	DENEGRE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
JZ2	JZ2	NNP	I-NP	O
UM638/985444	UM638/985444	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
51440	51440	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

VRBUIV1LUH	VRBUIV1LUH	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
6/10/01	6/10/01	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
6/10/01	6/10/01	CD	B-NP	O

